# Airmed Pathology Labs Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/airmed-pathology-labs-pvt

- Industry: Healthcare
- Headquarters: Ahmedabad, India
- Website: www.airmedlabs.com
- Total disclosed funding: $1.5M
- Latest round: Seed (Jan 27, 2017)
- Investors on record: 1

## About

Airmed Pathology Labs Pvt Ltd is an Indian company specializing in high-quality diagnostic testing services, offering a wide range of pathology tests and health packages tailored to individual health needs.Airmed Pathology Labs Pvt Ltd focuses on delivering comprehensive pathology services. The company, founded by Amit Gupta, Aradhana Gupta, and Piyush Gupta, is headquartered in Ahmedabad, India. In January 2017, Brand Capital led a Seed round, raising INR 100 million, marking it as a significant milestone in their funding journey. The company has achieved a total fundraising of INR 100 million from this investment.Airmed Labs specializes in providing a comprehensive range of pathology services, focusing on high-quality diagnostic testing that includes various blood tests, health checkups, and health packages. Their core offerings encompass essential health diagnostics such as lipid profiles, thyroid function tests, liver function tests, and specific health profiles targeting conditions like diabetes, heart health, and iron deficiency. Airmed Labs employs a user-friendly digital platform for booking tests, ensuring a seamless experience where customers can schedule appointments and receive reports via a mobile application. The primary client base consists of individual consumers seeking health assessments, as well as healthcare professionals recommending diagnostic services to their patients. Airmed Labs operates predominantly in metropolitan areas across India, including cities like Ahmedabad, Delhi, Kolkata, and Surat, catering to a growing demand for accessible and hygienic pathology services.In the most recent financial year 2024, Airmed Labs reported a revenue of INR 1,055,643.90 and an EBITDA of INR 474,396.10. The revenue model is structured around direct-to-consumer transactions for diagnostic testing services, with a focus on individual health needs. Customers can book a variety of tests and packages, such as the Advanced Body Profile priced at INR 2,399 and the Basic Body Profile available for INR 399. The company employs a straightforward payment process where customers pay at the time of booking, facilitating a smooth transaction without intermediary complexities. This model enhances customer convenience and allows Airmed Labs to maintain direct relationships with their clientele, ensuring personalized service and timely delivery of test results.Airmed Pathology Labs Pvt Ltd plans to leverage the recent funding from Brand Capital to enhance its service offerings and expand its market presence. The company is focused on designing new health packages and diagnostic tests aimed at diverse health conditions, with expected launches in the next fiscal year. Additionally, Airmed Labs aims to expand its operations into new metropolitan regions in India to meet increasing demand, targeting cities such as Mumbai and Bangalore by 2025. The strategic use of the INR 100 million raised in the Seed round will support these initiatives, improving infrastructure and marketing efforts to attract a broader customer base.

## Funding rounds

- Seed, Jan 27, 2017, $1.5M — Brand Capital

## Investors

- Brand Capital (https://capitalatlas.ai/funds/brand-capital) — Seed